Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Celldex Therapeutics (CLDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,122
  • Shares Outstanding, K 172,470
  • Annual Sales, $ 12,740 K
  • Annual Income, $ -93,030 K
  • 36-Month Beta 2.70
  • Price/Sales 4.56
  • Price/Cash Flow N/A
  • Price/Book 0.43
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.55
  • Most Recent Earnings -0.03 on 03/07/18
  • Next Earnings Date 11/06/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +52.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.30 +9.27%
on 10/30/18
0.47 -30.53%
on 10/17/18
-0.12 (-27.31%)
since 10/16/18
3-Month
0.30 +9.27%
on 10/30/18
0.52 -36.54%
on 08/28/18
-0.09 (-22.35%)
since 08/16/18
52-Week
0.30 +9.27%
on 10/30/18
3.09 -89.32%
on 12/11/17
-2.52 (-88.42%)
since 11/16/17

Most Recent Stories

More News
Celldex Presents Emerging MerTK Antibody Program at the Society for Immunotherapy of Cancer's 33rd Annual Meeting

Antibody technology provides an exciting new approach to enhance innate immune function in cancer

CLDX : 0.33 (-2.08%)
Celldex (CLDX) Q3 Earnings Beat Estimates, Revenues Miss

Celldex (CLDX) reports narrower-than-expected loss in Q3. Revenues fall on reduced contract revenues and also miss estimates.

CLDX : 0.33 (-2.08%)
LLY : 113.83 (+1.45%)
VRTX : 165.11 (-0.94%)
BMY : 54.07 (+1.50%)
Celldex Therapeutics (CLDX) Reports Q3 Loss, Lags Revenue Estimates

Celldex (CLDX) delivered earnings and revenue surprises of 46.67% and -54.76%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

CLDX : 0.33 (-2.08%)
Celldex: 3Q Earnings Snapshot

HAMPTON, N.J. (AP) _ Celldex Therapeutics Inc. (CLDX) on Wednesday reported a loss of $7.2 million in its third quarter.

CLDX : 0.33 (-2.08%)
Celldex Provides Corporate Update and Reports Third Quarter 2018 Results

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2018.

CLDX : 0.33 (-2.08%)
Report: Developing Opportunities within Adamis Pharmaceuticals, Cass Information, Celldex Therapeutics, Par Pacific, Inovio Pharmaceuticals, and Liberty Global -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Adamis Pharmaceuticals Corporation...

CASS : 67.57 (+0.19%)
CLDX : 0.33 (-2.08%)
PARR : 16.88 (+1.81%)
ADMP : 2.60 (-6.47%)
LBTYA : 24.31 (-1.66%)
INO : 5.12 (+1.79%)
Why Is Celldex (CLDX) Up 3.3% Since Last Earnings Report?

Celldex (CLDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CLDX : 0.33 (-2.08%)
Today's Research Reports on Trending Tickers: Celldex Therapeutics and Inovio Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / August 23, 2018 / U.S. markets were mixed on Wednesday, with the Dow Jones and S&P 500 finishing in the red, as the Federal Reserve meeting indicated another interest rate...

CLDX : 0.33 (-2.08%)
Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates

Celldex (CLDX) reports narrower-than-expected loss in Q2. Revenues fell due to reduced contract revenues.

CLDX : 0.33 (-2.08%)
LLY : 113.83 (+1.45%)
SGEN : 57.43 (+5.59%)
BMY : 54.07 (+1.50%)
Celldex Therapeutics (CLDX) Reports Q2 Loss, Tops Revenue Estimates

Celldex (CLDX) delivered earnings and revenue surprises of 21.43% and 2.52%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

CLDX : 0.33 (-2.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade CLDX with:

Business Summary

CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal...

See More

Key Turning Points

2nd Resistance Point 0.36
1st Resistance Point 0.34
Last Price 0.33
1st Support Level 0.32
2nd Support Level 0.32

See More

52-Week High 3.09
Fibonacci 61.8% 2.02
Fibonacci 50% 1.70
Fibonacci 38.2% 1.37
Last Price 0.33
52-Week Low 0.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar